Measuring the gains from medical research: an economic approach
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chicago
University of Chicago Press
c2003
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and indexes The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth.From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development.The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book |
| Beschreibung: | 1 Online-Ressource (vi, 263 p.) |
| ISBN: | 0226551792 9780226551784 9780226551791 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043156429 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2003 |||| o||u| ||||||eng d | ||
| 020 | |a 0226551792 |c electronic bk. |9 0-226-55179-2 | ||
| 020 | |a 9780226551784 |9 978-0-226-55178-4 | ||
| 020 | |a 9780226551791 |c electronic bk. |9 978-0-226-55179-1 | ||
| 035 | |a (OCoLC)642206239 | ||
| 035 | |a (DE-599)BVBBV043156429 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 362.1/068 |2 22 | |
| 245 | 1 | 0 | |a Measuring the gains from medical research |b an economic approach |c edited by Kevin M. Murphy and Robert H. Topel |
| 264 | 1 | |a Chicago |b University of Chicago Press |c c2003 | |
| 300 | |a 1 Online-Ressource (vi, 263 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and indexes | ||
| 500 | |a The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer | ||
| 500 | |a Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth.From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development.The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book | ||
| 650 | 4 | |a Médecine / Recherche / Coût-efficacité / Congrès | |
| 650 | 7 | |a MEDICAL / Administration |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Practice Management & Reimbursement |2 bisacsh | |
| 650 | 7 | |a Onderzoek |2 gtt | |
| 650 | 7 | |a Geneeskunde |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Kosten-batenanalyse |2 gtt | |
| 650 | 7 | |a Medicine / Research / Cost effectiveness |2 fast | |
| 650 | 4 | |a Research / Congresses / economics | |
| 650 | 4 | |a Cost-Benefit Analysis / Congresses | |
| 650 | 4 | |a Health Expenditures / Congresses / trends | |
| 650 | 4 | |a Health Status / Congresses | |
| 650 | 4 | |a Research Support as Topic / Congresses | |
| 650 | 4 | |a Socioeconomic Factors / Congresses | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Medicine |x Research |x Cost effectiveness |v Congresses | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Murphy, Kevin M. |e Sonstige |4 oth | |
| 700 | 1 | |a Topel, Robert H. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-226-55178-4 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028580620 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175622082134016 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043156429 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)642206239 (DE-599)BVBBV043156429 |
| dewey-full | 362.1/068 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.1/068 |
| dewey-search | 362.1/068 |
| dewey-sort | 3362.1 268 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04650nmm a2200601zc 4500</leader><controlfield tag="001">BV043156429</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2003 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0226551792</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-226-55179-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780226551784</subfield><subfield code="9">978-0-226-55178-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780226551791</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-226-55179-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)642206239</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043156429</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.1/068</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Measuring the gains from medical research</subfield><subfield code="b">an economic approach</subfield><subfield code="c">edited by Kevin M. Murphy and Robert H. Topel</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago</subfield><subfield code="b">University of Chicago Press</subfield><subfield code="c">c2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (vi, 263 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and indexes</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth.From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development.The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médecine / Recherche / Coût-efficacité / Congrès</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Administration</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Practice Management & Reimbursement</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Onderzoek</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneeskunde</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kosten-batenanalyse</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine / Research / Cost effectiveness</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research / Congresses / economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cost-Benefit Analysis / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Expenditures / Congresses / trends</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Status / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research Support as Topic / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Socioeconomic Factors / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield><subfield code="x">Research</subfield><subfield code="x">Cost effectiveness</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Murphy, Kevin M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Topel, Robert H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-226-55178-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028580620</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV043156429 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:13Z |
| institution | BVB |
| isbn | 0226551792 9780226551784 9780226551791 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028580620 |
| oclc_num | 642206239 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (vi, 263 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | University of Chicago Press |
| record_format | marc |
| spelling | Measuring the gains from medical research an economic approach edited by Kevin M. Murphy and Robert H. Topel Chicago University of Chicago Press c2003 1 Online-Ressource (vi, 263 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and indexes The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer Annotation In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated $18.4 billion to it, compared with only $3.7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth.From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending toolittleon medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly $10 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development.The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book Médecine / Recherche / Coût-efficacité / Congrès MEDICAL / Administration bisacsh MEDICAL / Practice Management & Reimbursement bisacsh Onderzoek gtt Geneeskunde gtt Geneesmiddelen gtt Kosten-batenanalyse gtt Medicine / Research / Cost effectiveness fast Research / Congresses / economics Cost-Benefit Analysis / Congresses Health Expenditures / Congresses / trends Health Status / Congresses Research Support as Topic / Congresses Socioeconomic Factors / Congresses Medizin Medicine Research Cost effectiveness Congresses (DE-588)1071861417 Konferenzschrift gnd-content Murphy, Kevin M. Sonstige oth Topel, Robert H. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 0-226-55178-4 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681 Aggregator Volltext |
| spellingShingle | Measuring the gains from medical research an economic approach Médecine / Recherche / Coût-efficacité / Congrès MEDICAL / Administration bisacsh MEDICAL / Practice Management & Reimbursement bisacsh Onderzoek gtt Geneeskunde gtt Geneesmiddelen gtt Kosten-batenanalyse gtt Medicine / Research / Cost effectiveness fast Research / Congresses / economics Cost-Benefit Analysis / Congresses Health Expenditures / Congresses / trends Health Status / Congresses Research Support as Topic / Congresses Socioeconomic Factors / Congresses Medizin Medicine Research Cost effectiveness Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Measuring the gains from medical research an economic approach |
| title_auth | Measuring the gains from medical research an economic approach |
| title_exact_search | Measuring the gains from medical research an economic approach |
| title_full | Measuring the gains from medical research an economic approach edited by Kevin M. Murphy and Robert H. Topel |
| title_fullStr | Measuring the gains from medical research an economic approach edited by Kevin M. Murphy and Robert H. Topel |
| title_full_unstemmed | Measuring the gains from medical research an economic approach edited by Kevin M. Murphy and Robert H. Topel |
| title_short | Measuring the gains from medical research |
| title_sort | measuring the gains from medical research an economic approach |
| title_sub | an economic approach |
| topic | Médecine / Recherche / Coût-efficacité / Congrès MEDICAL / Administration bisacsh MEDICAL / Practice Management & Reimbursement bisacsh Onderzoek gtt Geneeskunde gtt Geneesmiddelen gtt Kosten-batenanalyse gtt Medicine / Research / Cost effectiveness fast Research / Congresses / economics Cost-Benefit Analysis / Congresses Health Expenditures / Congresses / trends Health Status / Congresses Research Support as Topic / Congresses Socioeconomic Factors / Congresses Medizin Medicine Research Cost effectiveness Congresses |
| topic_facet | Médecine / Recherche / Coût-efficacité / Congrès MEDICAL / Administration MEDICAL / Practice Management & Reimbursement Onderzoek Geneeskunde Geneesmiddelen Kosten-batenanalyse Medicine / Research / Cost effectiveness Research / Congresses / economics Cost-Benefit Analysis / Congresses Health Expenditures / Congresses / trends Health Status / Congresses Research Support as Topic / Congresses Socioeconomic Factors / Congresses Medizin Medicine Research Cost effectiveness Congresses Konferenzschrift |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=322681 |
| work_keys_str_mv | AT murphykevinm measuringthegainsfrommedicalresearchaneconomicapproach AT topelroberth measuringthegainsfrommedicalresearchaneconomicapproach |